文献速递流行病学与生物统计临床试验与 GCP

N95口罩与医用口罩预防医务人员流感:一项随机临床试验

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2019-01-01

该集群随机实效性研究在美国7个医疗中心的137个门诊研究点开展,比较N95口罩与医用口罩在医务人员中预防流感和其他病毒性呼吸道感染的效果。结果显示,N95口罩组实验室确诊流感感染率为8.2%医务人员季节,医用口罩组为7.2%,差异无统计学意义(P=0.18)。

要点

  • 在门诊医务人员中,佩戴N95口罩与医用口罩相比,实验室确诊流感发生率无显著差异。
  • N95口罩组实验室确诊流感为8.2%医务人员季节,医用口罩组为7.2%(差异1.0%,95%CI -0.5%至2.5%;P=0.18)。
  • 其他呼吸道感染结局(急性呼吸道疾病、实验室检测呼吸道感染、实验室确诊呼吸道疾病、流感样疾病)两组间均无显著差异。

核心结论

  • 在门诊医务人员中,按本试验中参与者佩戴方式,N95口罩与医用口罩在实验室确诊流感发生率方面无显著差异。

研究设计与样本

  • 集群随机实效性研究,2011年9月至2015年5月在美国7个医疗中心的137个门诊研究点开展,最终随访至2016年6月。
  • 每年在12周病毒性呼吸道疾病高峰期内,将每个中心内的门诊点配对(集群)并随机分配至N95口罩组或医用口罩组,共4年。
  • 1993名参与者(189个集群)随机分配佩戴N95口罩(2512医务人员季节观察),2058名参与者(191个集群)随机分配佩戴医用口罩(2668医务人员季节)。
  • 2862名随机参与者中(平均[SD]年龄43[11.5]岁;2369名[82.8%]女性),2371名完成研究,共计5180医务人员季节。

主要发现

  • N95口罩组实验室确诊流感感染事件207例(8.2%医务人员季节),医用口罩组193例(7.2%医务人员季节),差异1.0%(95%CI -0.5%至2.5%;P=0.18),调整比值比(OR)1.18(95%CI 0.95-1.45)。
  • N95口罩组急性呼吸道疾病事件1556例 vs 医用口罩组1711例(差异-21.9/1000医务人员季节,95%CI -48.2至4.4;P=0.10)。
  • N95口罩组实验室检测呼吸道感染679例 vs 医用口罩组745例(差异-8.9/1000医务人员季节,95%CI -33.3至15.4;P=0.47)。
  • N95口罩组实验室确诊呼吸道疾病事件371例 vs 医用口罩组417例(差异-8.6/1000医务人员季节,95%CI -28.2至10.9;P=0.39)。
  • N95口罩组流感样疾病事件128例 vs 医用口罩组166例(差异-11.3/1000医务人员季节,95%CI -23.8至1.3;P=0.08)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Clinical studies have been inconclusive about the effectiveness of N95 respirators and medical masks in preventing health care personnel (HCP) from acquiring workplace viral respiratory infections. OBJECTIVE: To compare the effect of N95 respirators vs medical masks for prevention of influenza and other viral respiratory infections among HCP. DESIGN, SETTING, AND PARTICIPANTS: A cluster randomized pragmatic effectiveness study conducted at 137 outpatient study sites at 7 US medical centers between September 2011 and May 2015, with final follow-up in June 2016. Each year for 4 years, during the 12-week period of peak viral respiratory illness, pairs of outpatient sites (clusters) within each center were matched and randomly assigned to the N95 respirator or medical mask groups. INTERVENTIONS: Overall, 1993 participants in 189 clusters were randomly assigned to wear N95 respirators (2512 HCP-seasons of observation) and 2058 in 191 clusters were randomly assigned to wear medical masks (2668 HCP-seasons) when near patients with respiratory illness. MAIN OUTCOMES AND MEASURES: The primary outcome was the incidence of laboratory-confirmed influenza. Secondary outcomes included incidence of acute respiratory illness, laboratory-detected respiratory infections, laboratory-confirmed respiratory illness, and influenzalike illness. Adherence to interventions was assessed. RESULTS: Among 2862 randomized participants (mean [SD] age, 43 [11.5] years; 2369 [82.8%]) women), 2371 completed the study and accounted for 5180 HCP-seasons. There were 207 laboratory-confirmed influenza infection events (8.2% of HCP-seasons) in the N95 respirator group and 193 (7.2% of HCP-seasons) in the medical mask group (difference, 1.0%, [95% CI, -0.5% to 2.5%]; P = .18) (adjusted odds ratio [OR], 1.18 [95% CI, 0.95-1.45]). There were 1556 acute respiratory illness events in the respirator group vs 1711 in the mask group (difference, -21.9 per 1000 HCP-seasons [95% CI, -48.2 to 4.4]; P = .10); 679 laboratory-detected respiratory infections in the respirator group vs 745 in the mask group (difference, -8.9 per 1000 HCP-seasons, [95% CI, -33.3 to 15.4]; P = .47); 371 laboratory-confirmed respiratory illness events in the respirator group vs 417 in the mask group (difference, -8.6 per 1000 HCP-seasons [95% CI, -28.2 to 10.9]; P = .39); and 128 influenzalike illness events in the respirator group vs 166 in the mask group (difference, -11.3 per 1000 HCP-seasons [95% CI, -23.8 to 1.3]; P = .08). In the respirator group, 89.4% of participants reported "always" or "sometimes" wearing their assigned devices vs 90.2% in the mask group. CONCLUSIONS AND RELEVANCE: Among outpatient health care personnel, N95 respirators vs medical masks as worn by participants in this trial resulted in no significant difference in the incidence of laboratory-confirmed influenza. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01249625.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Radonovich LJ, Simberkoff MS, Bessesen MT, et al. N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial. JAMA. 2019. PMID: 31479137. doi:10.1001/jama.2019.11645

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。